How many insider trades does FilingIQ track for IMVT?

FilingIQ tracks 344 Form 4 insider transactions for IMVT (Immunovant, Inc.), covering filings from Dec 18, 2019 onwards. 38 of those were filed in the last 90 days.

Are IMVT insiders net buyers or net sellers?

Across the full Form 4 history for IMVT, 13 transactions (4%) were open-market purchases and 221 (64%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does IMVT insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

What sector is IMVT in?

Immunovant, Inc. (IMVT) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $5.64B.

IMVT insider trading

NasdaqGS Healthcare

Immunovant, Inc. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades

344

Last 90 days

Buys / sells

4% / 64%

Market cap

$5.64B

About Immunovant, Inc.

Immunovant, Inc., a clinical-stage immunology company, develops monoclonal antibodies for the treatment of autoimmune diseases. It develops IMVT-1402 for graves' disease, rheumatoid arthritis, myasthenia gravis, chronic inflammatory demyelinating polyneuropathy, cutaneous lupus erythematosus disease, and sjögren's disease; and batoclimab for myasthenia gravis, chronic inflammatory demyelinating polyneuropathy, and thyroid eye disease. The company was founded in 2018 and is based in New York, New York. Immunovant, Inc. is a subsidiary of Roivant Sciences Ltd.

Company website: immunovant.com

IMVT insider activity at a glance

FilingIQ has scored 344 insider transactions for IMVT since Dec 18, 2019. The most recent filing in our index is dated May 1, 2026.

Across the full history, 13 open-market purchases and 221 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on IMVT insider trades is 57.6/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live IMVT trades on FilingIQ Raw filings on SEC EDGAR

Latest IMVT Form 4 filings

Girao Tiago Chief Financial Officer

S Apr 23, 2026

Most recent disclosures. Sign up to filter by score, transaction code, or insider role.

Other Healthcare tickers with recent insider activity

UTHR 1,098

UNITED THERAPEUTICS Corp

APLS 279

Apellis Pharmaceuticals, Inc.

KMDA 218

KAMADA LTD

BMY 185

BRISTOL MYERS SQUIBB CO

ADPT 184

Adaptive Biotechnologies Corp

GH 169

Guardant Health, Inc.

ISRG 166

INTUITIVE SURGICAL INC

VTRS 165

Viatris Inc

Top insiders trading IMVT

Girao Tiago

3 trades · score 72.0

Venker Eric

67 trades · score 70.6

13F funds holding IMVT

PERCEPTIVE ADVISORS LLC

$48.61M · 1.7% of AUM

STEMPOINT CAPITAL LP

$26.71M · 7.9% of AUM

Rubric Capital Management LP

$21.87M · 0.8% of AUM

Logos Global Management LP

$15.18M · 1.2% of AUM

Frazier Life Sciences Management, L.P.

$10.40M · 0.6% of AUM

Frequently asked

How many insider trades does FilingIQ track for IMVT?: FilingIQ tracks 344 Form 4 insider transactions for IMVT (Immunovant, Inc.), covering filings from Dec 18, 2019 onwards. 38 of those were filed in the last 90 days.
Are IMVT insiders net buyers or net sellers?: Across the full Form 4 history for IMVT, 13 transactions (4%) were open-market purchases and 221 (64%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does IMVT insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is IMVT in?: Immunovant, Inc. (IMVT) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $5.64B.

Methodology & sources

Every IMVT insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.